From: Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study
Variable Mean ± SD (Range) | Insulin (n = 8) | Sulfonylurea (n = 5) | Metformin (n = 6) | Thiazoli-dinediones (n = 6) | P Value |
---|---|---|---|---|---|
ALT (U/L) Change/Yr | 1.8 ± 3.0 (-2.0 – 7.8) | 4.7 ± 8.6 (-2.5 – 19.0) | -2.8 ± 22.0 (-41.5 – 26.5) | -1.1 ± 7.7 (-11.0 – 9.5) (n = 5) | 0.757 |
FEV1 (%) Change/Yr | -0.3 ± 3.3 (-3.9 – 6.3) | 1.4 ± 9.6 (-9.0 – 13.0) | -1.2 ± 3.2 (-7.0 – 1.5) | 5.2 ± 7.8 (-2.5 – 20.0) | 0.422 |
Weight (kg) Change/Yr | 1.5 ± 2.2 (-1.2 – 6.3) | 0.5 ± 2.2 (-2.4 – 2.7) | 1.8 ± 3.9 (-3.3 – 8.5) | 4.3 ± 6.0 (0.3 – 16.0) | 0.384 |
HbA1c Change/Yr | -0.3 ± 0.2 (-0.5 – 0.1) | -0.8 ± 0.7 (-1.8 – -0.1) | -1.1 ± 1.4 (-3.2 – 0.6) | -0.6 ± 1.3 (-3.2 – 0.5) | 0.283 |